FAST GFR: Pilot Study to Evaluate the Safety of the FAST GFR Test in Patients.

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Chronic Kidney DiseaseAcute Kidney Injury
Interventions
DEVICE

75 mg / 6 mL VFI™

Visible fluorescent injectate, a mixture of two different molecular weight carboxymethyl dextran molecules (5 kD and 150 kD) with different fluorescent dye molecules attached.

Trial Locations (1)

35294-0007

University of Alabama Birmingham, Division of Nephrology, Birmingham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

FAST BioMedical

INDUSTRY